Biotech RadarJobs updated

COMPANY

BeyondSpring Pharmaceuticals

HQ: Florham Park, NJ source · beyondspringpharma.com ↗

Clinical Phase 3

Location: Florham Park, NJ · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Chemotherapy-induced Neutropenia Non-Small Cell Lung Cancer Non-squamous Non-Small Cell Lung Cance

6Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4) source ↗
  2. Trial start Phase 3: Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia source ↗
  3. Trial start 3: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 source ↗
  4. Trial start Phase 2: Plinabulin iv Solution in Prevention of TAC Induced Neutropenia source ↗
  5. Trial start 2: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 source ↗
  6. Trial start Phase 3: Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 6

RecordTitlePhaseStatusStartPrimary completion
NCT07361484Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)Phase 3Not yet recruitingDec 1, 2026Jun 1, 2029 (estimated)
NCT02504489Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLCPhase 3Completed2015-12Jul 21, 2021 (actual)
NCT03102606Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 33CompletedMay 29, 2018Dec 12, 2018 (actual)
NCT04345900Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 22CompletedApr 5, 2017Mar 20, 2018 (actual)
NCT03294577Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced NeutropeniaPhase 3Unknown status (ClinicalTrials.gov)Oct 23, 2019Sep 25, 2020 (actual)
NCT04227990Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaPhase 2CompletedNov 27, 2017Oct 15, 2018 (actual)
Feedback